Toxic epidermal necrolysis following dorzolamide eyedrops;Necrosis epidérmica tóxica por colirio de dorzolamida

Anales de Medicina Interna

Volumn 25, Issue 1, 2008, Pages 47-48

  Asensio Sanchez V M ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; DORZOLAMIDE; EYE DROPS; METRONIDAZOLE; PHENIRAMINE MALEATE; PREDNISOLONE;

AGED; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HOSPITALIZATION; HUMAN; LETTER; OPEN ANGLE GLAUCOMA; TOXIC EPIDERMAL NECROLYSIS;

AGED; DRUG THERAPY, COMBINATION; EPIDERMAL NECROLYSIS, TOXIC; EYE DISEASES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTENSIVE CARE; METRONIDAZOLE; OPHTHALMIC SOLUTIONS; PHENIRAMINE; PREDNISOLONE; SULFONAMIDES; THIOPHENES;

EID: 42049103694     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. García-Doval I, Roujeau J, Cruces M. Necrólisis epidérmica tóxica y síndrome de Stevens-Johnson: Clasificación y actualidad terapéutica. Actas Dermosifiliogr 2000; 91: 541-51.
2. Balfour JA, Wilde MI. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. Drug Aging 1997; 10: 384-403.
3. Schmutz JL, Barbaud A, Trechot P. Toxic epidermal necrolysis following eyedrop treatment for glaucoma. Ann Dermatol Venereol 2007; 134: 417.
4. Florez A, Rosón E, Conde A, González B, García-Doval I, de la Torre C, et al. Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops. J Am Acad Dermatol 2005; 53: 909-11.
5. Kumar S, Singh V, Tiwari M. Quantitative structure activity relationship studies of sulfamide derivatives as carbonic anhydrase inhibitor: As antiglaucoma agents. Med Chem 2007; 3: 379-86.